Shares of Athersys Inc. lost more than half their value in early trading on Wednesday after the Cleveland regenerative medicine company said it had priced a public stock offering at a significant discount.
Athersys shares (Nasdaq: ATHX) were down nearly 55% to 58 cents at 11 a.m. on Wednesday.
After the stock market closed on Monday, Athersys said it intended to sell common stock and warrants in a public offering to raise operating capital as it pursues licensing and other business development…
